Arvinas Inc (ARVN)
33.16
+0.92
(+2.85%)
USD |
NASDAQ |
May 31, 16:00
33.14
-0.02
(-0.06%)
After-Hours: 20:00
Arvinas Total Liabilities (Quarterly): 602.90M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 602.90M |
December 31, 2023 | 644.60M |
September 30, 2023 | 601.10M |
June 30, 2023 | 619.90M |
March 31, 2023 | 664.80M |
December 31, 2022 | 703.90M |
September 30, 2022 | 713.30M |
June 30, 2022 | 736.40M |
March 31, 2022 | 765.00M |
December 31, 2021 | 799.90M |
September 30, 2021 | 787.13M |
June 30, 2021 | 61.08M |
March 31, 2021 | 66.47M |
Date | Value |
---|---|
December 31, 2020 | 75.20M |
September 30, 2020 | 66.83M |
June 30, 2020 | 64.80M |
March 31, 2020 | 70.74M |
December 31, 2019 | 74.96M |
September 30, 2019 | 74.93M |
June 30, 2019 | 55.54M |
March 31, 2019 | 58.83M |
December 31, 2018 | 62.61M |
September 30, 2018 | 62.56M |
June 30, 2018 | 61.71M |
December 31, 2017 | 66.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
55.54M
Minimum
Jun 2019
799.90M
Maximum
Dec 2021
412.47M
Average
602.00M
Median
Total Liabilities (Quarterly) Benchmarks
Pfizer Inc | 128.54B |
Bristol-Myers Squibb Co | 82.48B |
Alnylam Pharmaceuticals Inc | 4.044B |
Rhythm Pharmaceuticals Inc | 197.07M |
IDEAYA Biosciences Inc | 26.22M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.213B |
Shareholders Equity (Quarterly) | 609.70M |
Debt to Equity Ratio | 0.0011 |
Current Ratio | 4.943 |
Net Debt Paydown Yield | 0.00% |